Here's what you need to know: Medicare Coverage (Effective Mid-2026) Following the November 2025 Trump administration agreements, Medicare will cover GLP-1 medications for obesity with: $50 monthly copay for eligible patients $245 government cost (down from $1,000+ list prices) Medicare Eligibility Requirements: BMI over 27 with prediabetes OR established cardiovascular disease, OR BMI over 30 with uncontrolled hypertension, kidney disease, or heart failure, OR BMI over 35 (severe obesity) Medicaid Coverage States can opt into $245 monthly pricing for all covered uses
Understanding GLP-1 Medications Before we dive into the thyroid connection, it is helpful to understand what these medications actually do
For those considering GLP-1s for weight loss, they can uncover underlying blood sugar issues
Push the plunger down slowly until it stops
Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)